CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 42 filers reported holding CABALETTA BIO INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,461,196 | +65.1% | 96,005 | +40.1% | 0.00% | – |
| Q2 2023 | $884,968 | +961.8% | 68,549 | +580.2% | 0.00% | – |
| Q1 2023 | $83,345 | -10.6% | 10,078 | 0.0% | 0.00% | – |
| Q4 2022 | $93,222 | -74.1% | 10,078 | -68.9% | 0.00% | – |
| Q1 2021 | $360,000 | -11.1% | 32,390 | 0.0% | 0.00% | – |
| Q4 2020 | $405,000 | +21.6% | 32,390 | +5.6% | 0.00% | – |
| Q3 2020 | $333,000 | -8.3% | 30,674 | -5.6% | 0.00% | – |
| Q2 2020 | $363,000 | +166.9% | 32,503 | +74.8% | 0.00% | – |
| Q1 2020 | $136,000 | -30.3% | 18,598 | +33.8% | 0.00% | – |
| Q4 2019 | $195,000 | – | 13,898 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,106,000 | $32,053,320 | 21.20% |
| COMMODORE CAPITAL LP | 2,525,753 | $38,441,961 | 4.49% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $30,440,000 | 3.40% |
| VR Adviser, LLC | 1,973,253 | $30,032,911 | 3.16% |
| Cormorant Asset Management, LP | 2,879,424 | $43,824,833 | 2.56% |
| Velan Capital Investment Management LP | 150,000 | $2,283,000 | 1.84% |
| Redmile Group, LLC | 1,774,252 | $27,004,115 | 1.28% |
| TCG Crossover Management, LLC | 486,795 | $7,409,020 | 1.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,340,118 | $35,616,596 | 0.78% |
| Integral Health Asset Management, LLC | 330,000 | $5,022,600 | 0.70% |